New combined therapy helps extend lives of men with prostate cancer
3 Articles
3 Articles
New combined therapy helps extend lives of men with prostate cancer
Practice-changing research shows that a combination of androgen deprivation therapy -- a commonly used hormone injection -- plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years.
New combined therapy helps extend lives of men with prostate cancer
Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients' prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium